RNPC3 and breast carcinoma: We used three different ways such as transfection of Cas9-sgRNA plasmid, Lipofectamine-mediated delivery of the RNP complex, and TAT-mediated delivery of the complex to introduce the Cas9 system into drug resistant breast cancer cells.